Key result
Chronic MK421 cuts mean arterial pressure ~43% in sodium-restricted rats despite normal angiotensin II levels.
Why the study?
The mechanisms underlying the hypotensive effect of the ACE inhibitor MK421 (enalapril) independent of angiotensin II formation blockade were unclear.
Does enalapril exert a vasodepressor effect independent of angiotensin II formation blockade in sodium-restricted rats?
Does enalapril exert a vasodepressor effect independent of angiotensin II formation blockade in sodium-restricted rats?
In a severe chronic sodium restriction model, the hypotensive effect of enalapril is mediated by factors other than the blockade of angiotensin II formation.
Answers are grounded in this paper and cite their sources.
Animal data on enalapril and Ang II in sodium-restricted rats; leaves open translation to human therapy.
Summary: The effects of acute and chronic angiotensin-converting enzyme (ACE) inhibition with MK421 (enalapril maleate) on angiotensin II formation were studied in sodium-restricted rats. Male Sprague-Dawley rats were placed on a low-sodium diet (<0.04 mEq Na+/24 h) with daily injections of furosemide (1 mg/kg i.p.) for 5 days, and were studied at either 5 days or 3 weeks. Half the rats were given MK421 (300 mg/L) in the drinking water. Parallel groups of rats were fed a standard diet (0.26 mEq Na+/24 h) without MK421. As expected, rats maintained on the low-sodium regimen for either 5 or 21 days had marked stimulation of plasma renin activity and increased angiotensin I, angiotensin II, and aldosterone formation. When MK421 was added to the drinking water, there was inhibition of angiotensin II formation at 5 days (low sodium, 99.4 ± 25.8 pg/ml; low sodium + MK421, 26.3 ± 10.5 pg/ml; p < 0.02), but angiotensin II formation at 3 weeks was not different from the control group (low sodium, 499 ± 147 pg/ml; low sodium + MK421, 306 ± 110 pg/ml). Plasma aldosterone levels closely paralleled those of angiotensin II in all groups (r = 0.94, p < 0.05) compatible with angiotensin II stimulation of aldosterone production, even in the face of ACE inhibition. The following lines of evidence, however, suggested decreased angiotensin II activity in MK421-treated rats at 3 weeks: (a) MK421-treated rats anesthetized with pentobarbital (50 mg/kg) were hypotensive (mean arterial pressure, 71.5 ± 8.7 vs. 125.7 ± 3.2 mm Hg; p < 0.001); (b) ACE was markedly suppressed (268 ± 11.4 vs. 1.50 ± 0.87 nmol/ml/min; p < 0.001); and (c) the pressor response to angiotensin I was blunted. Under conditions of severe chronic sodium restriction, the hypotensive effect of MK421 was dissociated from suppressed levels of plasma angiotensin II. Hypotension was not due to plasma volume contraction: plasma volume was expanded in the chronic low sodium + MK421 group compared with the group without MK421 (4.86 ± 0.13 vs. 3.61 ± 0.12 ml/100 g BW; p < 0.001). Serum sodium varied inversely with plasma volume (low sodium + MK421, 127.5 ± 4.3 mEq/L; without MK421, 144.8 ± 1.3 mEq/L; p < 0.001), suggesting a MK421-induced defect in water handling by the kidney. Chronic administration of MK421 was also associated with a striking rise in blood urea nitrogen level at both 5 days (normal controls, 14.3 ± 0.6 mg/dl; low sodium + MK421, 74.4 ± 9.9 mg/dl; p < 0.001) and 3 weeks (62.5 ± 17.4 mg/dl vs. normal controls; p < 0.001). These studies revealed multiple physiologic abnormalities and suggest that part of the hypotensive effect accompanying MK421 is mediated by factors other than blockade of angiotensin II formation.
No takes yet. Share an insight, caveat, or question.
Barry M. Wílkes (1984) studied Sodium restriction. MK421 (enalapril maleate) vs. Low sodium diet without MK421 was evaluated on Mean arterial pressure at 3 weeks (p=<0.001). In sodium-restricted rats, chronic MK421 administration induced severe hypotension despite normal plasma angiotensin II levels at 3 weeks.
Synapse has enriched 10 related papers. Consider them for comparative context: